Moody's (NYSE: MCO) director logs RSU dividend shares and equivalents

Rhea-AI Filing Summary

Moody's Corporation director Therese Esperdy reported a small automatic increase in her holdings due to dividend-related awards on 12/12/2025. She acquired 8.222 shares of common stock as an RSU deferred dividend reinvestment accrual at a price of $486.745 per share, bringing her directly held common stock to 4,700.662 shares.

She also received 0.845 dividend equivalent derivative units tied to an exempt grant of unvested RSUs, representing the right to receive the same number of common shares when the underlying RSUs vest and settle. After this transaction, she holds 3.423 dividend equivalent derivative securities in total, all reported as directly owned.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Esperdy Therese

(Last) (First) (Middle)

250 GREENWICH STREET

(7 WORLD TRADE CENTER)

(Street)

NEW YORK NY 10007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOODYS CORP /DE/ [ MCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		A		8.222(1)	A	$486.745	4,700.662	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent	(2)	12/12/2025		A		0.845		(2)	(2)	Common Stock	0.845	$0	3.423	D

Explanation of Responses:

1. RSU deferred dividend reinvestment accrual.

2. Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award.

Remarks:

	Elizabeth McCarroll, by power of attorney for Therese Esperdy	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Moody's (MCO) director Therese Esperdy report?

Director Therese Esperdy reported acquiring 8.222 shares of Moody's common stock on 12/12/2025 through an RSU deferred dividend reinvestment accrual, plus additional dividend equivalent units linked to unvested RSUs.

How many Moody's (MCO) shares does the director own after this Form 4 filing?

Following the reported transactions, Therese Esperdy directly holds 4,700.662 shares of Moody's common stock, as disclosed in the filing.

What was the price used for the RSU dividend reinvestment shares for Moody's (MCO)?

The 8.222 common shares credited to Therese Esperdy via RSU deferred dividend reinvestment were recorded at a price of $486.745 per share.

What are the dividend equivalent derivative securities reported for Moody's (MCO)?

The filing shows 0.845 dividend equivalent derivative securities acquired, each corresponding to 0.845 shares of common stock. These are dividend equivalents accrued on an exempt grant of unvested RSUs that will vest and settle together with the underlying RSU award.

How many dividend equivalent derivatives linked to Moody's (MCO) stock does the director now hold?

After the transaction, Therese Esperdy beneficially owns 3.423 dividend equivalent derivative securities, all reported as held directly.

What is the transaction date for the reported Moody's (MCO) insider activity?

The earliest transaction date disclosed for the common stock and dividend equivalent accruals is 12/12/2025.